Dr.med. ID: 2597367

Niklas Börschel

graph of relations

Publications

  1. 2022
  2. Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study

    Schönlein, M., Wrage, V., Ghandili, S., Mellinghoff, S. C., Brehm, T. T., Leypoldt, L. B., Utz, N., Schrader, R. M., Alsdorf, W., Börschel, N., Bußmann, L., Schönrock, M., Perlick, D., Schön, G., Verpoort, K., Lütgehetmann, M., Schulze Zur Wiesch, J., Weisel, K. C., Bokemeyer, C., Schafhausen, P. & Sinn, M., 13.06.2022, In: CANCER CELL. 40, 6, p. 581-583 3 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  3. 2015
  4. Potentiating the activity of rituximab against mantle cell lymphoma in mice by targeting interleukin-2 to the neovasculature

    Börschel, N., Schwöppe, C., Zerbst, C., Angenendt, L., Kessler, T., Klapper, W., Giovannoni, L., Elia, G., Neri, D., Berdel, W. E., Mesters, R. M. & Schliemann, C., 07.2015, In: Leukemia research. 39, 7, p. 739-48 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearch